This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Phase III Trial Comparing Methotrexate and Cetuxim...
Clinical trial

Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer (ELAN-UNFIT)

Read time: 1 mins
Last updated:18th Jun 2013

To test whether cetuximab improves efficacy/tolerance as compared to methotrexate in first line treatment of unfit patients 70 years old with recurrent and /or metastatic HNSCC. Efficacy assessed by failure free survival

Category Value
Study start date 2013-06-18

View full details